Lycopodium Alkaloids from Huperzia goebelii

Area of Science:

• Natural Product Chemistry
• Pharmacognosy
• Medicinal Chemistry

Background:

• Huperzia goebelii is a plant source of Lycopodium alkaloids.
• Lycopodium alkaloids exhibit diverse biological activities.
• Fawcettimine-type alkaloids possess unique structural features.

Purpose of the Study:

• To isolate and characterize new and known Lycopodium alkaloids from Huperzia goebelii.
• To elucidate the structure of the novel compound hupertimine F.
• To evaluate the in vitro inhibitory activities of isolated alkaloids against key enzymes.

Main Methods:

• Phytochemical investigation involving isolation and purification techniques.
• Structure elucidation using spectroscopic methods (1D/2D NMR, HRESIMS) and X-ray diffraction.
• In vitro enzyme inhibition assays for acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and monoamine oxidase B (MAO-B).

Main Results:

• Isolation of one new fawcettimine-type alkaloid, hupertimine F (1), and five known Lycopodium alkaloids (2-6).
• Determination of the structure of hupertimine F, characterized by a 5/5/5/5/6 pentacyclic system and a 1-aza-7-oxabicyclo[2.2.1]heptane moiety.
• Compounds 2, 3, 5, and 6 were reported from H. goebelii for the first time.
• Initial evaluation of compounds 1-6 for their inhibitory potential against AChE, BChE, and MAO-B.

Conclusions:

• Hupertimine F is a novel Lycopodium alkaloid with a unique pentacyclic structure.
• The study expands the known chemical diversity of Lycopodium alkaloids from Huperzia species.
• The isolated alkaloids warrant further investigation for their potential pharmacological activities, particularly enzyme inhibition.